Cited by 44Endometriosis Research and TreatmentEctopic Pregnancy Diagnosis and ManagementEndometrial and Cervical Cancer Treatments

Investigation of diagnostic potentials of nine different biomarkers in endometriosis

Ozhan, Erdem, Kokcu, Arif, Yanik, Keramettin, Gunaydin, Murat·2014·European Journal of Obstetrics & Gynecology and Reproductive Biology

Abstract

Objective To investigate the diagnostic potentials of the serum levels of nine different biomarkers in endometriosis.Study design In this case-controlled, prospective clinical study, 80 women underwent laparoscopy or laparotomy with a preliminary diagnosis of chronic pelvic pain, severe secondary dysmenorrhea, infertility, pelvic endometriosis or pelvic mass. The 60 women with confirmed pelvic endometriosis constituted the endometriosis group, and the other 20 women without endometriosis constituted the control group. Preoperative blood samples were obtained for serum biomarker measurements. Serum levels of nine different serum biomarkers including α-enolase, macrophage migration inhibitory factor, leptin, interleukin-8, anti-endometrial antibody, phosphoinositide dependent protein kinase 1, CA125, syntaxin-5, and laminin-1 were measured concurrently and compared between the control and endometriosis groups, and among control group and endometriosis subgroups including stage I, stage II, stage III and stage IV endometriosis.Results The serum levels of α-enolase, macrophage migration inhibitory factor, leptin, interleukin-8 and antiendometrial antibodies showed a statistically significant difference neither between control and endometriosis groups nor among control group and endometriosis subgroups. The serum levels of CA125, syntaxin-5 and laminin-1 showed a statistically significant difference both between the control and endometriosis groups (p<0.01) and among control group and endometriosis subgroups (p<0.01). Serum levels of laminin-1 in stage II and IV endometriosis; syntaxin-5 in stage I and II endometriosis; and CA125 in stage III and IV endometriosis were found to have the different levels compared to control group.Conclusions These findings show that the concurrent measurement of CA125, syntaxin-5 and laminin-1 might be a useful non-invasive test in strengthening the diagnosis of endometriosis and in predicting its severity.

Integrity signals

Registry

Crossref · 10.1016/j.ejogrb.2014.04.037

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Ozhan et al. stated that a panel of CA-125, syntaxin-5, and laminin-1 had 90% sensitivity, 70% specificity, and 88.7% accuracy to distinguish endometriosis patients (n=60) from controls (n=20).

    “Ozhan et al. stated that a panel consisting of CA-125, syntaxin-5, and laminin-1 had 90% sensitivity, 70% specificity, and 88.7% accuracy to distinguish endometriosis patients (n = 60) from controls (n = 20) [41].”

    From Update on biomarkers for the detection of endometriosis (2015) · cites this paper as [41]

Cites

Flagged first, then by citations

1 of the 33 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Ozhan, E., Kokcu, A., Yanik, K., & Gunaydin, M.
Affiliations
Ondokuz Mayıs University (TR)
Venue
European Journal of Obstetrics & Gynecology and Reproductive Biology
Publisher
Elsevier BV
Published
2014-07
Volume
178
Pages
128-133
ISSN
  • 0028-2243 (ISSN-L)
  • 0301-2115
OpenAlex
W2169935875
Cited by
44
References
33
Citations by year
2026: 2 · 2025: 5 · 2024: 7 · 2023: 2 · 2022: 5 · 2021: 3 · 2020: 5 · 2019: 3 · 2018: 4 · 2017: 1 · 2016: 4 · 2015: 3
FWCI
3.23
Type
journal article
Language
en
Open access
closed
Locations
  • European Journal of Obstetrics & Gynecology and Reproductive Biology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ectopic Pregnancy Diagnosis and Management
  • Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
Keywords
endometriosis, serum biomarkers, CA125, syntaxin 5, laminin-1, non-invasive diagnosis, endometriosis severity, endometriosis staging, alpha-enolase, macrophage migration inhibitory factor, leptin, interleukin-8, anti-endometrial antibodies, phosphoinositide-dependent protein kinase 1
MeSH terms
Adult, Endometriosis, Female, Humans, Laminin, Prospective Studies, Biomarkers, Case-Control Studies, CA-125 Antigen, Qa-SNARE Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review